fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and..
.
..
labour�s new study is based on freedom of information data from 95 english nhs trust...treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk (file pic)